STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		77 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011
Revenues	$ 0	$ 0	$ 0
Operating expenses:
Research and development	691,699	750,128	14,936,917
Refund credit for research and development costs	0	0	(420,842)
General and administrative	448,729	361,216	9,350,291
Total operating expenses	1,140,428	1,111,344	23,866,366
Loss from operations	(1,140,428)	(1,111,344)	23,866,366
Other income (expenses)
Interest income, net	8,904	1,993	(174,228)
Non cash interest on convertible debentures	0	0	(73,930)
Non cash interest expense on beneficial conversion feature of convertible debentures	0	0	(713,079)
Change in fair market value of derivatives	(8,452)	11,860	122,262
Total other income (expenses)	452	13,853	(490,519)
Loss before income taxes	(1,139,976)	(1,097,491)	(24,356,885)
Income tax provision	0	0	0
Net loss	$ (1,139,976)	$ (1,097,491)	$ (24,356,885)
Net loss per common share - basic and diluted (in dollars per share)	$ (0.01)	$ (0.01)
Weighted average common shares outstanding - basic and diluted (in shares)	144,570,447	135,471,689